Skip to content

Apparent diffusion coefficient radiomics for differentiating benign and malignant PI-RADS 3-5 prostate lesions: external validation.

Aug 2026 · International Urology and Nephrology · 0 citations · 27 references
Medicine

TL;DR

ADC radiomics provided complementary information for differentiating benign and malignant PI-RADS 3-5 prostate lesions, but its incremental value beyond the clinical model was limited.

View source

Similar papers

Review Open access Aug 2026

An Apparent Diffusion Coefficient-Based Radiomics Tool for Clinically Significant Prostate Cancer Detection in PI-RADS 3 Lesions: A Multicenter Study.

RATIONALE AND OBJECTIVES The clinical management of Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions remains controversial due to their equivocal likelihood of clinically significant prostate cancer (csPCa). This study aimed to develop and validate a prediction model for csPCa detection to assist in clini...

G. Gao, Ke-Xin Wang, Xiao-Ying Wang et al. · 0 citations
Open access Aug 2026

ADC-based radiomics for risk stratification in prostate cancer: a clinical decision support study

A minimal-feature radiomics model derived exclusively from ADC images showed promising diagnostic performance for differentiating malignant from benign prostate lesions, and may provide a practical, reproducible, and resource-efficient strategy for supporting prostate cancer diagnosis.

Kun Zhang, Jia-Jun Zhang, Yangguang Yuan et al. · 0 citations
Sep 2026

A Quantitative Nomogram Integrating IVIM-derived True Diffusion Coefficient and PSAD for Predicting Clinically Significant Prostate Cancer: Comparison With PI-RADS-based Assessment.

RATIONALE AND OBJECTIVES To develop and validate a quantitative nomogram integrating the intravoxel incoherent motion (IVIM)-derived true diffusion coefficient (D) and prostate-specific antigen density (PSAD) for predicting clinically significant prostate cancer (csPCa) in patients with elevated serum PSA, and to compa...

Xiao-Bo Wang, Yi-Ze Li, Zi-Qi Chen et al. · 0 citations
Open access Aug 2026

Diagnostic value of whole-tumor ADC histogram parameters combined with ISUP grade and MRI-EPE score for predicting extracapsular extension in PI-RADS 4–5 prostate cancer

Purpose To investigate the incremental value of whole-tumor apparent diffusion coefficient (ADC) histogram parameters, when combined with clinical pathological variables for predicting extracapsular extension (EPE) in patients with PI-RADS 4–5 prostate cancer. Methods This retrospective study included 102 patients with...

Lei Yi, Yue Gu, X. Xie et al. · 0 citations
Open access Sep 2026

Tumor apparent diffusion coefficient combined with the lipid-to-creatine ratio for preoperative differentiation of primary central nervous system lymphoma from high-grade glioma: a single-center diagnostic model development and internal validation study

Background and purpose Primary central nervous system lymphoma (PCNSL) and high-grade glioma (HGG) may share overlapping conventional MRI appearances. We developed and internally validated a parsimonious model combining tumor apparent diffusion coefficient (ADC) and the lipid-to-creatine ratio (Lip/Cr), compared it wit...

Lei Geng, Su-Bo Zhang, Zhao-Ting Zhang et al. · 0 citations
Open access Sep 2026

MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer

Objectives To characterize recurrence heterogeneity among patients with VI-RADS 2 non-muscle-invasive bladder cancer (NMIBC) and to develop and internally validate a recurrence-free survival (RFS) prediction model incorporating quantitative MRI features. Methods This retrospective study included 342 patients with patho...

Jun-Peng Sun, Ziyong Wang, Maoa Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.